Stock Market & Financial Investment News

News Breaks October 10, 2012 09:35 EDT OSUR OraSure rises after launch of OraQuick In-Home HIV test for U.S. consumers OraSure is trading up over 5.6% at time of writing following news yesterday that the company's OraQuick In-Home HIV test is now available to U.S. consumers at retailers nationwide and online. Resistance is at $11.02. Support is at $10.71. News For OSUR From The Last 14 Days Check below for free stories on OSUR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 8, 2013 16:04 EDT OSUR OraSure sees Q2 EPS (15c)-(16c), consensus (14c) Sees Q2 revenue $23.5M-$24M, consensus $23.39M. 16:03 EDT OSUR OraSure reports Q1 EPS (18c), consensus (18c) Subscribe for More Information May 7, 2013 07:24 EDT OSUR Mizuho Securities to host a conference Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.